ASCO 2019: Successes and setbacks mark the cancer meeting
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
Cancer (Oncology)
Combining biologics and small molecules for cancer
Interviewee/Contributor
Amrik Basran
Organisation
Avacta Life Sciences
Single-arm studies set the pace of oncology
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
The productivity of oncology development continues
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
Genmab looks ahead to next phase of growth
Interviewee/Contributor
Jan van de Winkel
Organisation
Genmab A/S
The oncology drug success rate is improving
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
After probing the unknown, BerGenBio finds a gem
Interviewee/Contributor
Richard Godfrey
Organisation
BerGenBio ASA
How basket trials are changing cancer research
Interviewee/Contributor
Shiva Memari
Organisation
Vertical Knowing
Battle looms over immunotherapy combination
Interviewee/Contributor
Robin Davison
Organisation
New Science Global Healthcare Fund
Targeting the genetic background of cancers
Interviewee/Contributor
Niall Martin and Jonathan Tobin
Organisation
Artios Pharma Ltd